Evidence for Magnesium Sulfate as a Tocolytic Agent
- 1 October 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 52 (10) , 652-658
- https://doi.org/10.1097/00006254-199710000-00023
Abstract
The objective of our study is to quantitatively examine the available evidence regarding the efficacy and side effects of magnesium sulfate for acute tocolysis (from randomized trials) compared with placebo and beta-agonist agents. Randomized trials comparing magnesium sulfate with placebo or beta-agonists for tocolysis were identified with a MEDLINE-based search and was supplemented by a search of obstetrical textbooks and bibliographies. Trials underwent quality evaluation and data abstraction by two independent, blinded investigators. Outcomes evaluated included delivery delay of various durations as well as the frequency of major and minor side effects. Summary odds ratios and 95 percent confidence intervals for dichotomous outcomes were calculated using a random effects model. Interstudy heterogeneity for these outcomes was assessed with a Q statistic. We identified 12 randomized controlled trials of magnesium sulfate for acute tocolysis. Four studies were excluded because of either lack of comparison of magnesium sulfate to either placebo or beta-agonists or lack of reporting clinical outcomes of interest. The eight remaining randomized trials comparing magnesium sulfate with placebo or beta-agonists were included in this analysis. There was no significant difference between MgSO4 and placebo for any of the measured outcomes for delay in delivery. Comparing magnesium sulfate to ritodrine or beta-agonists did not demonstrate any differences between the agents in achieving clinically significant tocolysis. There was a significant difference between MgSO4 and beta-agonists in the frequency of medication discontinuation because of side effects, but not in the frequency of major adverse drug events. There are few data comparing magnesium sulfate with a placebo for acute tocolysis. Magnesium sulfate seems to be comparable to ritodrine and beta-agonists, although the available data are not sufficient for a rational choice between these agents.Keywords
This publication has 17 references indexed in Scilit:
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993
- A national survey on preterm laborAmerican Journal of Obstetrics and Gynecology, 1989
- A comparison of statistical methods for combining event rates from clinical trialsStatistics in Medicine, 1989
- Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agentsAmerican Journal of Obstetrics and Gynecology, 1988
- Magnesium sulfate and ritodrine hydrochloride: A randomized comparisonAmerican Journal of Obstetrics and Gynecology, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm laborAmerican Journal of Obstetrics and Gynecology, 1985
- The use of ritodrine and magnesium sulfate in the arrest of premature laborInternational Journal of Gynecology & Obstetrics, 1984
- Magnesium sulfate as a tocolytic agentAmerican Journal of Obstetrics and Gynecology, 1983
- A method for assessing the quality of a randomized control trialControlled Clinical Trials, 1981